Publicacións en colaboración con investigadores/as de Universidade de Vigo (30)

2024

  1. Characterization and modulation of voltage-gated potassium channels in human lymphocytes in schizophrenia

    Schizophrenia Research, Vol. 270, pp. 260-272

  2. Cognitive and clinical predictors of a long-term course in obsessive compulsive disorder: A machine learning approach in a prospective cohort study

    Journal of Affective Disorders, Vol. 350, pp. 648-655

  3. Plasma IGFBP-3 and IGFBP-5 levels are decreased during acute manic episodes in bipolar disorder patients

    Frontiers in Pharmacology, Vol. 15

2023

  1. Human Breast Milk microRNAs, Potential Players in the Regulation of Nervous System

    Nutrients, Vol. 15, Núm. 14

  2. MiRNA Differences Related to Treatment-Resistant Schizophrenia

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

  3. Proteomic analysis of exosomes derived from human mature milk and colostrum of mothers with term, late preterm, or very preterm delivery

    Analytical Methods, Vol. 15, Núm. 37, pp. 4905-4917

2022

  1. Changes in the Brain Extracellular Matrix Composition in schizophrenia: A Pathophysiological Dysregulation and a Potential Therapeutic Target

    Cellular and Molecular Neurobiology, Vol. 42, Núm. 6, pp. 1921-1932

  2. Efficacy and Safety of Lithium Treatment in SARS-CoV-2 Infected Patients

    Frontiers in Pharmacology, Vol. 13

2021

  1. Early intervention services, patterns of prescription and rates of discontinuation of antipsychotic treatment in first-episode psychosis

    Early Intervention in Psychiatry, Vol. 15, Núm. 6, pp. 1584-1594

  2. Proteomic and metabolic profiling of chronic patients with schizophrenia induced by a physical activity program: Pilot study

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 3, pp. 125-138

  3. The role of the second extracellular loop of norepinephrine transporter, neurotrophin-3 and tropomyosin receptor kinase C in T cells: A peripheral biomarker in the etiology of schizophrenia

    International Journal of Molecular Sciences, Vol. 22, Núm. 16

  4. Voices 2: Improving Prosodic Recognition in Schizophrenia With an Online Rehabilitation Program

    Frontiers in Psychology, Vol. 12

2020

  1. A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine

    Frontiers in Psychiatry, Vol. 11

  2. Brainwaves Oscillations as a Potential Biomarker for Major Depression Disorder Risk

    Clinical EEG and Neuroscience, Vol. 51, Núm. 1, pp. 3-9

  3. Plasma β-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune Pathways

    Frontiers in Psychiatry, Vol. 10

2018

  1. Cytokines dysregulation in schizophrenia: A systematic review of psychoneuroimmune relationship

    Schizophrenia Research, Vol. 197, pp. 19-33

  2. Serotonin syndrome versus neuroleptic malignant syndrome: a case report

    Actas Espanolas de Psiquiatria

2017

  1. Diagnosing psychopathy through emotional regulation tasks: Heart rate variability versus implicit association test

    Psychopathology, Vol. 50, Núm. 5, pp. 334-341

2015

  1. Linguistic analysis of suicide notes in Spain

    European Journal of Psychiatry, Vol. 29, Núm. 2, pp. 145-155